Medtronic to spin out diabetes division as $2.8B independent player
The medtech giant said it aims to complete the spinoff within the next 18 months, with the goal of taking the new company public through an IPO.
The medtech giant said it aims to complete the spinoff within the next 18 months, with the goal of taking the new company public through an IPO.
